Taylor Hanley

Analyst

J.P. Morgan

Equibles does not estimate personal net worth.

About Taylor Hanley

Taylor Hanley is recorded as Analyst at J.P. Morgan. Taylor Hanley has spoken on 2 earnings calls and 1 other investor event across 2 companies, most recently for Regeneron Pharmaceuticals, Inc. on July 30, 2026. Those appearances were for Regeneron Pharmaceuticals, Inc. (REGN) and Biogen Inc. (BIIB). The companies whose calls Taylor Hanley spoke on are classified in the Healthcare sector.

Taylor Hanley on recent calls

“We were just wondering, given some of the recent updates in the broader I&I space, can you talk a bit more about your latest thoughts on expanding the Sanofi collaboration to include additional assets, and then also what steps you could take to accelerate the development of those assets.”

Analyst — J.P. Morgan, Regeneron Pharmaceuticals, Inc. Q2 FY2026 Earnings Call · July 30, 2026

“We were just wondering, can you give some thoughts or color on how you're thinking about the commercial potential for dyrinurcin versus Lakembi and Kassanla, just when you're comparing both their efficacy and their safety profile?”

Analyst — J.P. Morgan, Biogen at the Alzheimer's Association International Conference (AAIC) 2026 · July 14, 2026

“We were just wondering on LIBTIO, can you provide any color on the drivers of performance this quarter? Was there anything one time in there? How much of this was driven by the new indication CSCC?”

Analyst — J.P. Morgan, Regeneron Pharmaceuticals, Inc. Q1 FY2026 Earnings Call · April 29, 2026